A flow of new contracts have been announced so far in December adding to the evidence of business progress. The relatively new biometrics department reported a new client, Global Antibiotic Research & Development Partnership (GARDP). This is a not-for-profit research and development organisation that addresses global public health needs by developing new or improved antibiotic treatments, while endeavouring to ensure sustainable access. GARDP has several locations worldwide including Brazil, Ind ....
12 Dec 2025
Hybridan Research: Physiomics plc
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
Hybridan Research: Physiomics plc
Physiomics Plc (PYC:LON) | 0.3 0 (-8.6%) | Mkt Cap: 0.80m
- Published:
12 Dec 2025 -
Author:
Jon Levinson | Hybridan Team -
Pages:
8 -
A flow of new contracts have been announced so far in December adding to the evidence of business progress. The relatively new biometrics department reported a new client, Global Antibiotic Research & Development Partnership (GARDP). This is a not-for-profit research and development organisation that addresses global public health needs by developing new or improved antibiotic treatments, while endeavouring to ensure sustainable access. GARDP has several locations worldwide including Brazil, Ind ....